30-60 mg (extended release) PO once daily; may be increased every 7-14 days PRN; not to exceed 90 mg/day (Adalat CC) or 120 mg/day (Procardia XL) Pulmonary Hypertension 30 mg (extended-release) PO q12hr; may be increased to 120-240 mg/day (monitor) Raynaud Phenomenon (Off-label...
Procardia Substitution?Procardia Xl Gits PillProcardia XL Gits Pill
PROCARDIA XL is a registered trademark for Nifedipine GITS. Nifedipine GITS (Gastrointestinal Therapeutic System) Tablet is formulated as a once-a-day controlled-release tablet for oral administration designed to deliver 30, 60, or 90 mg of nifedipine. Inert ingredients in the formulations are: ...
Related to Procardia xl:Calcium channel blockers,Nifedical XL ni·fed·i·pine (nī-fĕd′ə-pēn′) n. A calcium channel blocker drug, C17H18N2O6, that acts as a coronary vasodilator and is used primarily to treat hypertension and angina pectoris. ...
PROCARDIA XL Extended Release Tablet is similar in appearance to a conventional tablet. It consists, however, of a semipermeable membrane surrounding an osmotically active drug core. The core itself is divided into two layers: an "active" layer containing the drug, and a "push" layer containing...
美国上市药品目录集提供Procardia Xl的基本信息,包括Procardia Xl的申请号19684,申请类型,活性成分Nifedipine,中文名称硝苯地平,申请机构,批准日期等药品信息,更多美国药品Procardia Xl的信息查询就在戊戌数据美国上市药品数据库.
Before using Procardia XLIn deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:...
网络硝苯地平渗透泵片;硝苯地平控释片 网络释义
英文名:PROCARDIA XL Extended Release Tablet 规格:60mg 持证商:Pfizer Laboratories Div Pfizer Inc 上市国:美国 NDC:0069-2660-66 在线询价 您正在向SciMed America LLC发送关于产品硝苯地平控释片 PROCARDIA XLExtended Release Tablet 60mg的询问 *联系人: 当前还未登录,登录后可在线询价,马上登录或注册...
PROCARDIA XL®Extended Release Tablet is similar in appearance to a conventional tablet. It consists, however, of a semipermeable membrane surrounding an osmotically active drug core. The core itself is divided into two layers: an “active” layer containing the drug, and a “push” layer cont...